REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07543055 updates: 1. start date: 2026-08-10 → 2026-09-10 2. completion date: 2031-04-25 → 2031-06-27 3. primary completion date: 2030-02-05 → 2030-02-02
Clinical trial NCT07543055 updates: 1. start date: 2026-08-10 → 2026-09-10 2. completion date: 2031-04-25 → 2031-06-27 3. primary completion date: 2030-02-05 → 2030-02-02
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical